Publication information: “SAISEIKEN CO.,LTD.succeed an exploratory clinical study to evaluate the Stem Cell from Human exfoliated Deciduous teeth derived Conditioned Medium()for the treatment of amyotrophic lateral sclerosis(ALS)
This research result was published online on Friday, February 18, 2022, in the International scientific journal Neurology and Neuro Rehabilitation 2022,Vol. 4, Issue 2, 011-015.
Neurology and Neurorehabilitation 2022, Vol. 4, Issue 2, 011-015
The First in Human Case of Amyotrophic Lateral Sclerosis Treated with Stem Cell-Derived Conditioned Medium: A 1-Year- Follow Up
Minoru Ueda1,2* and Yasuhiro Seta3
1Department of Medicine, Postgraduate School of Medicine, Emeritus of Nagoya University, Nagoya, Japan 2President of SAISEIKEN Co. LTD, Tokyo, Japan
3Director of Smart Clinic Tokyo, Tokyo, Japan